PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH-Reference-Cited by-同舟云学术

PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH

Published:2011-09 Issue:1 Volume:218 Page:69-76
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Baron Morgane,Leroyer Aurélie S.,Majd Zouher,Lalloyer Fanny,Vallez Emmanuelle,Bantubungi Kadiombo,Chinetti-Gbaguidi Giulia,Delerive Philippe,Boulanger Chantal M.,Staels Bart,Tailleux Anne

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis;Bayturan;Arch Intern Med,2010

2. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease;Parekh;Gastroenterology,2007

3. Review: nonalcoholic steatohepatitis;Ludwig;J Gastroenterol Hepatol,1997

4. Atherosclerosis

5. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis;Boring;Nature,1998

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insight into increased risk of portal vein thrombosis in nonalcoholic fatty liver disease;European Journal of Internal Medicine;2023-08

2. Nitric Oxide Regulation in Microparticles;Nitric Oxide: From Research to Therapeutics;2023

3. Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research;International Journal of Molecular Sciences;2022-12-13

4. Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways;Clinical Science;2022-09

5. Review article: vascular effects of PPARs in the context of NASH;Alimentary Pharmacology & Therapeutics;2022-06-05